NDC 68462-206

Moexipril Hydrochloride and Hydrochlorothiazide

Moexipril Hydrochloride And Hydrochlorothiazide

Moexipril Hydrochloride and Hydrochlorothiazide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Moexipril Hydrochloride; Hydrochlorothiazide.

Product ID68462-206_45df7b71-b418-4b22-a0a5-d12916b7b53f
NDC68462-206
Product TypeHuman Prescription Drug
Proprietary NameMoexipril Hydrochloride and Hydrochlorothiazide
Generic NameMoexipril Hydrochloride And Hydrochlorothiazide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2010-03-18
Marketing CategoryANDA / ANDA
Application NumberANDA090718
Labeler NameGlenmark Pharmaceuticals Inc., USA
Substance NameMOEXIPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Active Ingredient Strength15 mg/1; mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68462-206-01

100 TABLET, FILM COATED in 1 BOTTLE (68462-206-01)
Marketing Start Date2010-03-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68462-206-01 [68462020601]

Moexipril Hydrochloride and Hydrochlorothiazide TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-03-18
Marketing End Date2019-09-11

NDC 68462-206-10 [68462020610]

Moexipril Hydrochloride and Hydrochlorothiazide TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090718
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-03-18
Marketing End Date2019-09-11

NDC 68462-206-30 [68462020630]

Moexipril Hydrochloride and Hydrochlorothiazide TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090718
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-03-18
Marketing End Date2019-09-11

Drug Details

Active Ingredients

IngredientStrength
MOEXIPRIL HYDROCHLORIDE15 mg/1

OpenFDA Data

SPL SET ID:e71002c8-3463-4950-b984-c4eee356a5f2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1299859
  • 1299890
  • 1299871

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    Medicade Reported Pricing

    68462020601 MOEXIPRIL-HYDROCHLOROTHIAZIDE 15-12.5 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Moexipril Hydrochloride and Hydrochlorothiazide" or generic name "Moexipril Hydrochloride And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0093-5213Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    0093-5214Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    0093-5215Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    23155-035Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    23155-036Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    23155-037Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    42291-576Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    42291-577Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    42291-578Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-205Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-206Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-207Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.